معرفی
Timothy J. Deming is currently the Chair of the Bioengineering Department at the University of California, Los Angeles (UCLA), where he holds the position of Professor. He leads a research group focused on the development and application of polypeptide-based materials for various biomedical applications.
Dr. Deming received his B.S. in Chemistry from the University of California, Irvine in 1989, followed by a Ph.D. in Chemistry from the University of California, Berkeley in 1993, where he worked under Bruce Novak. He then completed an NIH postdoctoral fellowship at the University of Massachusetts, Amherst with David Tirrell before joining the faculty at the University of California, Santa Barbara in 1995. At UCSB, he held joint appointments in the Materials and Chemistry Departments, where he was promoted to Associate Professor in 1999 and Full Professor in 2003.
Dr. Deming's research focuses on the synthesis, processing, characterization, and evaluation of biological and biomimetic materials based on polypeptides. His work explores how these materials, which can be prepared from renewable resources, offer biocompatibility, biodegradability, and unique self-assembling properties. His group utilizes innovative chemistry techniques to synthesize materials with properties that rival the complexity found in biological systems. The polymers are processed into ordered assemblies and characterized for both nanoscale structure and biological function. This interdisciplinary approach has led to advancements in drug and gene delivery, tissue engineering, neural regeneration, and responsive biomaterials.
Analysis of Dr. Deming's recent publications reveals a strong focus on polypeptide chemistry with applications spanning multiple disciplines. His work demonstrates expertise in developing novel polypeptide synthesis methods, creating responsive materials through chemical modifications (particularly sulfur-based switches), and applying these materials to challenging biomedical problems including neural regeneration, cancer treatment, and reconstructive surgery. The interdisciplinary nature of his research bridges chemistry, materials science, and biomedical engineering, with a particular emphasis on translating fundamental discoveries into practical biomedical applications.
Dr. Deming has received numerous prestigious awards and honors throughout his career, including:
- Fulbright-Tocqueville Distinguished Chair Award (2015-2016)
- Fellow of the American Institute for Medical and Biological Engineering (2010)
- Herbert Newby McCoy Award (UCLA Dept. of Chem. & Biochem., 2008)
- IUPAC Macromolecular Division, Samsung-IUPAC Young Scientist Award (2004)
- Materials Research Society Young Investigator Award (2003)
- Camille Dreyfus Teacher-Scholar Award (2000)
- Beckman Young Investigator Award (1998)
- Alfred P. Sloan Research Fellow (1998)
- National Science Foundation CAREER Award (1997)
- Office of Naval Research Young Investigator (1996)
Dr. Deming's research has been consistently supported by major funding agencies, including the National Science Foundation, Office of Naval Research, Arnold and Mabel Beckman Foundation, Alfred P. Sloan Foundation, Camille and Henry Dreyfus Foundation, and the Materials Research Society. His laboratory has trained numerous graduate students and postdoctoral researchers who have gone on to successful careers in academia and industry. Current research directions include the development of novel polypeptide-based hydrogels for neural tissue engineering, responsive materials for targeted drug delivery, and biomimetic systems that replicate the complexity of biological materials.
The Deming Research Group operates state-of-the-art facilities for polypeptide synthesis, characterization, and biological evaluation. The laboratory maintains strong collaborative relationships with researchers across multiple disciplines, including neuroscience, oncology, and materials science. Current projects focus on translating fundamental discoveries in polypeptide chemistry into practical applications for regenerative medicine, cancer therapy, and neural repair.
